Corporate Information And Statement Of Ifrs Compliance [Abstract]

Ascelia Pharma - Filing #689421

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification
Legal form of entity
Country of incorporation
Address of entity's registered office
Description of nature of entity's operations and principal activities
utvecklar
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade payables
15 881 SEK
6 147 SEK
Disclosure of assets and liabilities with significant risk of material adjustment [text block]

Talk to a Data Expert

Have a question? We'll get back to you promptly.